Urologix Inc. (ULGX)

Overview

Urologix, Inc. is a pioneering company focused on the development, manufacture, marketing, and distribution of minimally invasive medical products designed primarily to address obstruction and symptoms associated with benign prostatic hyperplasia (BPH). Founded in 1991 and headquartered in Minneapolis, Minnesota, Urologix has established itself as a leader in providing innovative treatments that offer a mix of effectiveness and patient comfort. By concentrating on minimally invasive methods, the company supports patients and clinicians in managing BPH with innovative and efficient healthcare solutions.

Products and Services

• Cooled ThermoTherapy:

This product stands as Urologix's innovative approach to BPH treatment, utilizing targeted microwave energy. The treatment focuses on heating the prostate to reduce tissue and alleviate symptoms of BPH, while simultaneously employing a cooling mechanism. This dual-action design ensures the protection of healthy tissue surrounding the treatment area and maximizes patient comfort during the procedure. Cooled ThermoTherapy represents a significant step forward in the non-invasive treatment of BPH, offering patients a beneficial alternative to traditional surgical methods.

• Prostiva RF Therapy System:

Another cornerstone of Urologix's product line is the Prostiva RF Therapy System. This system uses radiofrequency energy to directly target the prostate, effectively destroying problematic prostate tissue that contributes to urethral constriction and the associated symptoms of BPH. The direct application of energy offers a precise, controlled method for reducing prostate size and relieving urinary symptoms, allowing patients to experience significant improvements in their quality of life without the need for more invasive surgical procedures.